Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000892712-25-000006
Filing Date
2025-01-10
Accepted
2025-01-10 11:58:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8677
  Complete submission text file 0000892712-25-000006.txt   10312
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Subject) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91969 | Film No.: 25521638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 250 EAST WISCONSIN AVENUE SUITE 1250 MILWAUKEE WI 53202
Business Address
Barnard Robert James (Filed by) CIK: 0001979656 (see all company filings)

Type: SCHEDULE 13G/A